Skip to main content

letter

. 1993 May 22;306(6889):1410. doi: 10.1136/bmj.306.6889.1410-a

Uses of heparin. Ancrod for heparin induced thrombocytopenia.

R L Soutar, J S Ginsberg

PMCID: PMC1677806 PMID: 8518620

1410

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Chesterman C. N., Chong B. H. Uses of heparin. BMJ. 1993 Apr 3;306(6882):871–872. doi: 10.1136/bmj.306.6882.871. [DOI] [PMC free article] [PubMed] [Google Scholar]
Chong B. H., Ismail F., Cade J., Gallus A. S., Gordon S., Chesterman C. N. Heparin-induced thrombocytopenia: studies with a new low molecular weight heparinoid, Org 10172. Blood. 1989 May 1;73(6):1592–1596. [PubMed] [Google Scholar]
Cole C. W., Fournier L. M., Bormanis J. Heparin-associated thrombocytopenia and thrombosis: optimal therapy with ancrod. Can J Surg. 1990 Jun;33(3):207–210. [PubMed] [Google Scholar]
Demers C., Ginsberg J. S., Brill-Edwards P., Panju A., Warkentin T. E., Anderson D. R., Turner C., Kelton J. G. Rapid anticoagulation using ancrod for heparin-induced thrombocytopenia. Blood. 1991 Nov 1;78(9):2194–2197. [PubMed] [Google Scholar]
Latallo Z. S. Retrospective study on complications and adverse effects of treatment with thrombin-like enzymes--a multicentre trial. Thromb Haemost. 1983 Aug 30;50(2):604–609. [PubMed] [Google Scholar]

ACTIONS

RESOURCES